Sorry, but Notd.io is not available without javascript Ban on negotiating Medicare drug prices under pressure - notd.io

Read more about Ban on negotiating Medicare drug prices under pressure
Read more about Ban on negotiating Medicare drug prices under pressure
Ban on negotiating Medicare drug prices under pressure

By RICARDO ALONSO-ZALDIVAR WASHINGTON (AP) — Donna Weiner looks at Medicare’s prescription drug program from two different points of view. As a participant, she wants to pay less for her medicines, which cost her about $6,000 a year. As a retired accountant who spent 50 years handling the books for companies, she sees a way to get there. “You know from working in a business that it makes no sense for

You can publish here, too - it's easy and free.